Literature DB >> 35470258

A Dual Role for Cysteinyl Leukotriene Receptors in the Pathogenesis of Corneal Infection.

Thomas W Carion1, Yuxin Wang1, Ashten Stambersky1, Abdul Shukkur Ebrahim1, Elizabeth A Berger2.   

Abstract

Cysteinyl leukotrienes (CysLTs) have been defined as central mediators of inflammation. Despite our extensive understanding of these bioactive lipid mediators in the pathogenesis of diseases such as asthma, allergic rhinitis, and even neurological disorders, information regarding the eye is markedly lacking. As a result, this study examined the expression profiles of two major CysLT receptors, CysLT1 and CysLT2, in the cornea using experimental mouse models of Pseudomonas aeruginosa-induced keratitis with contrasting outcomes: susceptible C57BL/6 (B6) and resistant BALB/c. Postinfection, disparate levels of CysLT receptors were accompanied by distinct expression profiles for select proinflammatory and anti-inflammatory cell surface markers detected on macrophages and polymorphonuclear neutrophils between the two strains. Further, inhibition of either CysLT receptor converted the disease response of both strains, where corneal perforation was prevented in B6 mice, and BALB/c mice fared significantly worse. In addition, receptor antagonist studies revealed changes in inflammatory cell infiltrate phenotypes and an influence on downstream CysLT receptor signaling pathways. Although the B6 mouse model highlights the established proinflammatory activities related to CysLT receptor activation, results generated from BALB/c mice indicate a protective mechanism that may be essential to disease resolution. Further, basal expression levels of CysLT1 and CysLT2 were significantly higher in uninfected corneas of both mouse strains as opposed to during infection, suggestive of a novel role in homeostatic maintenance within the eye. In light of these findings, therapeutic targeting of CysLT receptors extends beyond inhibition of proinflammatory activities and may impact inflammation resolution, as well as corneal surface homeostasis.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35470258      PMCID: PMC9117469          DOI: 10.4049/jimmunol.2100474

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  88 in total

1.  Possible new role for NF-kappaB in the resolution of inflammation.

Authors:  T Lawrence; D W Gilroy; P R Colville-Nash; D A Willoughby
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 2.  VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis.

Authors:  Thomas W Carion; David Kracht; Eliisa Strand; Edwin David; Cody McWhirter; Abdul Shukkur Ebrahim; Elizabeth A Berger
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-12-04       Impact factor: 3.072

3.  A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock.

Authors:  Mihaela Gadjeva; Michal F Tomczak; Ming Zhang; Yan Yan Wang; Karen Dull; Arlin B Rogers; Susan E Erdman; James G Fox; Michael Carroll; Bruce H Horwitz
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

4.  A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.

Authors:  William R Henderson; Li-Ou Tang; Shi-Jye Chu; Shih-Ming Tsao; Gertrude K S Chiang; Falaah Jones; Mechthild Jonas; Chong Pae; Huaijing Wang; Emil Y Chi
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

5.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

Authors:  Haihong Zhong; Michael J May; Eijiro Jimi; Sankar Ghosh
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

6.  Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors.

Authors:  Hua Hu; Gao Chen; Jian-min Zhang; Wei-ping Zhang; Lei Zhang; Qiu-fu Ge; Hong-tian Yao; Wei Ding; Zhong Chen; Er-qing Wei
Journal:  Acta Pharmacol Sin       Date:  2005-06       Impact factor: 6.150

7.  NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.

Authors:  S Beinke; J Deka; V Lang; M P Belich; P A Walker; S Howell; S J Smerdon; S J Gamblin; S C Ley
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone-marrow-derived macrophages to Toll-like receptor agonists.

Authors:  Amrita D Joshi; Tracy Raymond; Ana L Coelho; Steven L Kunkel; Cory M Hogaboam
Journal:  J Leukoc Biol       Date:  2007-11-20       Impact factor: 4.962

9.  Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes.

Authors:  Bruce D Levy; Raja-Elie E Abdulnour; Alexander Tavares; Thayse R Brüggemann; Paul C Norris; Yan Bai; Xingbin Ai; Charles N Serhan
Journal:  J Allergy Clin Immunol       Date:  2019-10-14       Impact factor: 10.793

10.  The effects of montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture-induced sepsis.

Authors:  Ali Kagan Coskun; Murat Yigiter; Akgun Oral; Fehmi Odabasoglu; Zekai Halici; Oner Mentes; Elif Cadirci; Fadime Atalay; Halis Suleyman
Journal:  ScientificWorldJournal       Date:  2011-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.